- Report
- February 2021
Global
From €2824EUR$2,960USD£2,403GBP
- Report
- February 2021
Global
From €2824EUR$2,960USD£2,403GBP
- Report
- February 2021
Global
From €2824EUR$2,960USD£2,403GBP
- Report
- February 2021
Global
From €2824EUR$2,960USD£2,403GBP
- Drug Pipelines
- February 2023
- 33 Pages
Global
From €19074EUR$19,990USD£16,226GBP
- Report
- May 2022
- 548 Pages
Global
From €2385EUR$2,500USD£2,029GBP
- Report
- May 2022
- 1381 Pages
Global
From €2385EUR$2,500USD£2,029GBP
- Report
- December 2021
- 42 Pages
Global
From €3812EUR$3,995USD£3,243GBP
- Report
- December 2021
- 127 Pages
Global
From €10491EUR$10,995USD£8,925GBP
- Clinical Trials
- October 2021
- 1175 Pages
Global
From €2385EUR$2,500USD£2,029GBP
- Clinical Trials
- August 2021
- 263 Pages
Global
From €2385EUR$2,500USD£2,029GBP
- Report
- October 2018
- 124 Pages
Global
From €10491EUR$10,995USD£8,925GBP
- Drug Pipelines
- November 2020
- 423 Pages
Global
From €1908EUR$2,000USD£1,623GBP
- Drug Pipelines
- November 2020
- 251 Pages
Global
From €1908EUR$2,000USD£1,623GBP
- Drug Pipelines
- November 2020
- 1084 Pages
Global
From €2385EUR$2,500USD£2,029GBP
- Drug Pipelines
- September 2020
- 175 Pages
Global
From €1908EUR$2,000USD£1,623GBP
- Drug Pipelines
- June 2020
- 55 Pages
Global
From €1908EUR$2,000USD£1,623GBP
- Drug Pipelines
- June 2020
- 327 Pages
Global
From €1908EUR$2,000USD£1,623GBP
- Drug Pipelines
- June 2020
- 2766 Pages
Global
From €2385EUR$2,500USD£2,029GBP
- Drug Pipelines
- December 2019
- 53 Pages
Global
From €3340EUR$3,500USD£2,841GBP
The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease.
Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer.
Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more